Conversely, miR-204 targets SIRT1 to enhance the chemosensitivity of PCa cells to doxorubicin by promoting p53 acetylation, which in turn, activates pro-apoptotic proteins NOXA and PUMA [151]. Here, SIRT1 is linked to posterior cortical atrophy.